{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:09:45Z","timestamp":1788318585546,"version":"build-2803163510"},"reference-count":120,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.2217\/fmb-2017-0270","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T16:29:58Z","timestamp":1515774598000},"page":"507-524","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":43,"title":["Secnidazole: Next-Generation Antimicrobial agent for Bacterial Vaginosis Treatment"],"prefix":"10.1080","volume":"13","author":[{"given":"Paul","family":"Nyirjesy","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, Drexel University College of Medicine, 216 North Broad Street, 4th Floor, Philadelphia, PA19103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R","family":"Schwebke","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 703 19th Street South, ZRB 230, Birmingham, AL35294-0007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2001.00124.x"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.08.016"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181788301"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31820fc3b8"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283021a37"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001251"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31824e4bdb"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/657320"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8545(03)00086-X"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.02.048"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/375819"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-10"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/423963"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi243"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/561909"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0146-0005(98)80012-8"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.339"},{"key":"e_1_3_2_20_1","volume-title":"Preterm Birth: Causes, Consequences, and Prevention","author":"Behrman RE","year":"2007","unstructured":"Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Preterm Birth: Causes, Consequences, and Prevention . BehrmanRE, ButlerAS( Eds ). National Academies Press, Washington, DC, USA (2007)."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.03.047"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512283332603"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11009.x"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(94)70033-8"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002243420802"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(03)00107-6"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8545(21)00410-1"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198009113031102"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(92)91368-K"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/324445"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.8.2746-2749.2002"},{"key":"e_1_3_2_32_1","unstructured":"Sobel JD . Bacterial vaginosis. Up-to-date. 1\u201328 (2013). www.uptodate.com\/contents\/bacterial-vaginosis ."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043802"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-1-200807010-00006"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2011.03.016"},{"issue":"03","key":"e_1_3_2_36_1","first-page":"1","article-title":"Sexually transmitted treatment guidelines, 2015","volume":"64","author":"Workowski K","year":"2015","unstructured":"Workowski K , BolanA, Centers for Disease Control and Prevention . Sexually transmitted treatment guidelines, 2015. MMWR Recomm. Rep.64 (RR-03), 1\u2013137 (2015).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_37_1","unstructured":"Clindesse\u00ae (clindamycin phosphate) Vaginal Cream 2% Prescribing Information. Perrrigo . November 2014 . www.clindesse.com\/pdf\/PI.pdf ."},{"key":"e_1_3_2_38_1","unstructured":"Flagyl ER\u00ae (metronidazole extended-release tablets) Prescribing Information. Pharmacia. August 2003 . www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020868s008lbl.pdf ."},{"key":"e_1_3_2_39_1","unstructured":"NuvessaTM (metronidazole vaginal gel 1.3%) Prescribing Information. Actavis Pharma Inc. January 2015 . https:\/\/medlibrary.org\/lib\/rx\/meds\/nuvessa\/ ."},{"key":"e_1_3_2_40_1","unstructured":"Tindamax\u00ae (tinidazole tablets) Prescribing Information. Mission Pharmacal Company May 2007 . https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a0d01539-8413-4703-94cc-d221918630a1 ."},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/503780"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000135990.21755.51"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6602.814"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199651040-00007"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1086\/648093"},{"key":"e_1_3_2_46_1","unstructured":"Solosec\u00ae (secnidazole oral granules) Prescribing Information. Symbiomix Therapeutics LLC. September 2017 . www.drugs.com\/solosec.html ."},{"key":"e_1_3_2_47_1","unstructured":"Food and Drug Administration . Guidance for industry: expedited programs for serious conditions \u2013 drugs and biologics. May 2014 . www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm358301.pdf ."},{"key":"e_1_3_2_48_1","unstructured":"Secnol Patient Information Leaflet . http:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63820798&typedoc=N ."},{"key":"e_1_3_2_49_1","first-page":"69","article-title":"The nitroimidazole family of drugs (editorial)","volume":"54","author":"Anonymous","year":"1978","unstructured":"Anonymous . The nitroimidazole family of drugs (editorial). Br. J. Ven. Dis.54, 69\u201371 (1978).","journal-title":"Br. J. Ven. Dis."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/5.5.499"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.1.9"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.2.201"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02852.x"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1294-5501(05)80457-1"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936050-00004"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2017.05.005"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.05.033"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.5.720"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.083"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1806.111590"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00338.x"},{"issue":"4","key":"e_1_3_2_62_1","first-page":"172","article-title":"Acquisition of Helicobacter pylori infection and reinfection after its eradication are uncommon in Indian adults","volume":"19","author":"Bapat MR","year":"2000","unstructured":"Bapat MR , AbrahamP, BhandarkarPV, PhadkeAY, JoshiAS . Acquisition of Helicobacter pylori infection and reinfection after its eradication are uncommon in Indian adults. Indian J. Gastroenterol.19 (4), 172\u2013174 (2000).","journal-title":"Indian J. Gastroenterol."},{"issue":"5","key":"e_1_3_2_63_1","first-page":"191","article-title":"Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study","volume":"20","author":"Kumar D","year":"2001","unstructured":"Kumar D , AhujaV, DharA, SharmaMP . Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study. Indian J. Gastroenterol.20 (5), 191\u2013194 (2001).","journal-title":"Indian J. Gastroenterol."},{"issue":"1","key":"e_1_3_2_64_1","first-page":"7","article-title":"Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer","volume":"21","author":"Kumar D","year":"2002","unstructured":"Kumar D , DharA, DattaguptaS, AhujaV, MathurM, SharmaMP . Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer. Indian J. Gastroenterol.21 (1), 7\u201310 (2002).","journal-title":"Indian J. Gastroenterol."},{"key":"e_1_3_2_65_1","volume-title":"Secnidazole: A New Approach in 5-Nitroimidazole Therapy","author":"Frydman A","year":"1989","unstructured":"Frydman A , LemarM, Le RouxY . A review of the pharmacokinetics of secnidazole in man. In : Secnidazole: A New Approach in 5-Nitroimidazole Therapy . KatzN, WillisA( Eds ). Proceedings of the 16th International Congress of Chemotherapy. Jerusalem, Israel, 11\u201316 June 1989 ."},{"issue":"1","key":"e_1_3_2_66_1","first-page":"S71","article-title":"A Phase I study to determine the single dose safety and pharmacokinetics of SYM-1219 (secnidazole) in healthy female volunteers: P11\u2013042","volume":"97","author":"Pentikis HS","year":"2015","unstructured":"Pentikis HS , AdetoroN, BraunCJ . A Phase I study to determine the single dose safety and pharmacokinetics of SYM-1219 (secnidazole) in healthy female volunteers: P11\u2013042. Clin. Pharmacol. Therapy.97 (S1), S71 (2015).","journal-title":"Clin. Pharmacol. Therapy."},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.406"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1993.tb00398.x"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.758"},{"issue":"11","key":"e_1_3_2_70_1","first-page":"723","article-title":"Evaluation of the bioequivalence and pharmacokinetics of two formulations of secnidazole after single oral administration in healthy volunteers","volume":"57","author":"Zhu DQ","year":"2007","unstructured":"Zhu DQ , HuKL, TaoWXet al. Evaluation of the bioequivalence and pharmacokinetics of two formulations of secnidazole after single oral administration in healthy volunteers. Arzneimittelforschung57 (11), 723\u2013726 (2007).","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"e_1_3_2_71_1","first-page":"41","article-title":"Comparative pharmacokinetics of metronidazole in healthy volunteers and in patients suffering from amoebiasis","volume":"24","author":"Ashiq B","year":"2011","unstructured":"Ashiq B , UsmanM, AshrafM, OmerO, KhokharMI, Saeed-ul-HassanS . Comparative pharmacokinetics of metronidazole in healthy volunteers and in patients suffering from amoebiasis. Pak. J. Pharm.24 (1&2), 41\u201346 (2011).","journal-title":"Pak. J. Pharm."},{"key":"e_1_3_2_72_1","unstructured":"Secnol (secnidazole) summary of product characteristics . http:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=63820798&typedoc=R ."},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1159\/000221906"},{"issue":"2","key":"e_1_3_2_74_1","first-page":"77","article-title":"Secnidazole. A 5-imidazole derivation with a long half-life","volume":"54","author":"Videau D","year":"1978","unstructured":"Videau D , NielG, SibouletA, CatalanF . Secnidazole. A 5-imidazole derivation with a long half-life. Br J. Vener. Dis.54 (2), 77\u201380 (1978).","journal-title":"Br J. Vener. Dis."},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0411-9"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(91)90129-S"},{"issue":"5","key":"e_1_3_2_77_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0026-895X(25)13356-7","article-title":"Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450","volume":"33","author":"Guengerich FP","year":"1988","unstructured":"Guengerich FP . Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Mol. Pharmacol.33 (5), 500\u2013508 (1988).","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"e_1_3_2_78_1","first-page":"2073","article-title":"Update on oral contraceptive pills","volume":"60","author":"Cerel-Suhl SL","year":"1999","unstructured":"Cerel-Suhl SL , YeagerBF . Update on oral contraceptive pills. Am. Fam. Phys.60 (7), 2073\u20132084 (1999).","journal-title":"Am. Fam. Phys."},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.086"},{"key":"e_1_3_2_80_1","unstructured":"Flagyl\u00ae (metronidazole tablets) Prescribing Information. Pfizer. May 2017 . http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=570 ."},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91112-9"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.2.297-301.1991"},{"key":"e_1_3_2_83_1","unstructured":"Food and Drug Administration . Bacterial vaginosis: developing drugs for treatment. Draft Guidance. Issued July 2016. www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM510948.pdf ."},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.017"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002135"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/705692"},{"issue":"4","key":"e_1_3_2_87_1","first-page":"198","article-title":"Multicenter study, double-blind, randomized comparative between secnidazole and tinidazole in the treatment of non-specific vaginitis [in Portugese]","volume":"11","author":"Bagnoli VR","year":"1992","unstructured":"Bagnoli VR , KesselringGL . Multicenter study, double-blind, randomized comparative between secnidazole and tinidazole in the treatment of non-specific vaginitis [in Portugese]. Rev. Bras. Med.11 (4), 198\u2013202 (1992).","journal-title":"Rev. Bras. Med."},{"issue":"4","key":"e_1_3_2_88_1","first-page":"198","article-title":"Treatment of non-specific vaginitis with secnidazole and metronidazole","volume":"111","author":"Hegg R","year":"1992","unstructured":"Hegg R , RibeiroRM, BagnoliVRet al. Treatment of non-specific vaginitis with secnidazole and metronidazole. Rev. Bras. Med.111 (4), 198\u2013202 (1992).","journal-title":"Rev. Bras. Med."},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.11.028"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(98)00029-0"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.93859"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.036"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03260005"},{"key":"e_1_3_2_94_1","first-page":"173","article-title":"Itraconazole and secnidazole capsules vs. vaginal ovules of fluocinolone acetonide, nystatin and metronidazole in the symptomatic treatment of vaginitis [Article in Spanish]","volume":"66","author":"Alvarado Garc\u00eda A","year":"1998","unstructured":"Alvarado Garc\u00eda A , Gavi\u00f1o AmbrizS . Itraconazole and secnidazole capsules vs. vaginal ovules of fluocinolone acetonide, nystatin and metronidazole in the symptomatic treatment of vaginitis [Article in Spanish]. Ginecol. Obstet. Mex.66, 173\u2013178 (1998).","journal-title":"Ginecol. Obstet. Mex."},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-005-0071-5"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2005.10.012"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199707000-00008"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-31802005000300004"},{"issue":"4","key":"e_1_3_2_99_1","first-page":"260","article-title":"Entamoeba histolytica durante el embarazo: Patogenia y tratamiento","volume":"6","author":"Mendiet P","year":"2000","unstructured":"Mendiet P , \u00c1vilaD . Entamoeba histolytica durante el embarazo: Patogenia y tratamiento. Medicina (Guayaquil).6 (4), 260\u2013262 (2000).","journal-title":"Medicina (Guayaquil)."},{"key":"e_1_3_2_100_1","first-page":"476","article-title":"Tratamiento de la vaginitis por tricomonas con secnidazol en dosis unica","volume":"5","author":"Bravo AA","year":"1978","unstructured":"Bravo AA , VazquezRQ, FarrugiaDL . Tratamiento de la vaginitis por tricomonas con secnidazol en dosis unica. Invest. Med. Int.5, 476\u2013482 (1978).","journal-title":"Invest. Med. Int."},{"issue":"4","key":"e_1_3_2_101_1","first-page":"202","article-title":"A single dose of secnidazole in the treatment of vaginal trichomoniasis: a comparative study of morning and evening doses","volume":"91","author":"Machado D","year":"1988","unstructured":"Machado D , MachadoLE . A single dose of secnidazole in the treatment of vaginal trichomoniasis: a comparative study of morning and evening doses. J. Trop. Med. Hyg.91 (4), 202\u2013204 (1988).","journal-title":"J. Trop. Med. Hyg."},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2251-4"},{"issue":"4","key":"e_1_3_2_103_1","first-page":"197","article-title":"Tratamento da tricomoniase com dose unica de secnidazol (14.539 RP)","volume":"34","author":"Piato A","year":"1977","unstructured":"Piato A , CymbalistaN . Tratamento da tricomoniase com dose unica de secnidazol (14.539 RP). Rev. Bras. Med.34 (4), 197\u2013200 (1977).","journal-title":"Rev. Bras. Med."},{"issue":"6","key":"e_1_3_2_104_1","first-page":"365","article-title":"Tratamento da tricomoniase urogenital (ensaio clinico o 14.539 RP (secnidazol)","volume":"34","author":"Rocha AM","year":"1977","unstructured":"Rocha AM , Sarraff NetoA . Tratamento da tricomoniase urogenital (ensaio clinico o 14.539 RP (secnidazol). Rev. Bras. Med.34 (6), 365\u2013356 (1977).","journal-title":"Rev. Bras. Med."},{"issue":"5","key":"e_1_3_2_105_1","first-page":"527","article-title":"Treatment of amibiasis with short-term secnidazole therapy","volume":"42","author":"Cesari J","year":"1982","unstructured":"Cesari J , CondatM, GendronY, Saint-AndreP, ThomasJ, CharmotG . Treatment of amibiasis with short-term secnidazole therapy. Med. Trop. (Mars).42 (5), 527\u2013530 (1982).","journal-title":"Med. Trop. (Mars)."},{"issue":"6","key":"e_1_3_2_106_1","first-page":"159","article-title":"Effect of single dose of secnidazole in treatment of intestinal amoebiasis","volume":"45","author":"Omrani G","year":"1995","unstructured":"Omrani G , Rastegar-LariA, KhamsehM . Effect of single dose of secnidazole in treatment of intestinal amoebiasis. J. Pak. Med. Assoc.45 (6), 159 (1995).","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200020020-00003"},{"issue":"4","key":"e_1_3_2_108_1","first-page":"93","article-title":"Efficacy of secnidazole in the treatment of intestinal amoebiasis","volume":"44","author":"Qureshi H","year":"1994","unstructured":"Qureshi H , BaqaiR, ZuberiSJ, AhmedW, QureshiSA . Efficacy of secnidazole in the treatment of intestinal amoebiasis. J. Pak. Med. Assoc.44 (4), 93\u201394 (1994).","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.26719\/1999.5.2.389"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702003000200002"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1177\/004947559402400423"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/636857"},{"issue":"10","key":"e_1_3_2_113_1","first-page":"288","article-title":"Secnidazole in the treatment of giardiasis","volume":"45","author":"Baqai R","year":"1995","unstructured":"Baqai R , QureshiH, ZuberiSJ . Secnidazole in the treatment of giardiasis. J. Pak. Med. Assoc.45 (10), 288 (1995).","journal-title":"J. Pak. Med. Assoc."},{"issue":"5","key":"e_1_3_2_114_1","first-page":"241","article-title":"Evaluation of secnidazole gel and tinidazole suspension in the treatment of giardiasis in children","volume":"1","author":"Cimerman B","year":"1997","unstructured":"Cimerman B , Camilo CouraL, C SalleJMet al. Evaluation of secnidazole gel and tinidazole suspension in the treatment of giardiasis in children. Braz. J. Infect. Dis.1 (5), 241\u2013247 (1997).","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"e_1_3_2_115_1","first-page":"179","article-title":"Clinical trial with secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis","volume":"41","author":"Di Prisco MC","year":"2000","unstructured":"Di Prisco MC , Jim\u00e9nezJC, Rodr\u00edguezNet al. Clinical trial with secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis. Invest. Clin.41 (3), 179\u2013188 (2000).","journal-title":"Invest. Clin."},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349803235002380"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/42.3.184"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2011.08.005"},{"key":"e_1_3_2_119_1","first-page":"53","article-title":"Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess","volume":"17","author":"Bhatia S","year":"1998","unstructured":"Bhatia S , KarnadD, OakJ . Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian J. Gastroenterol.17, 53\u201354 (1998).","journal-title":"Indian J. Gastroenterol."},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702003000200002"},{"key":"e_1_3_2_121_1","article-title":"A Phase III, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis","author":"Chavoustie SE","year":"2017","unstructured":"Chavoustie SE , GerstenJK, SamuelMJ, SchwebkeJR . A Phase III, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis. J. Women's Health (2017) ( In Press ).","journal-title":"J. Women's Health"},{"issue":"4","key":"e_1_3_2_122_1","first-page":"260","article-title":"Entamoeba histolytica durante el embarazo: patogenia y tratamiento","volume":"6","author":"Chispe PM","year":"2000","unstructured":"Chispe PM , StaggDA . Entamoeba histolytica durante el embarazo: patogenia y tratamiento. Revista Medicina6 (4), 260\u2013262 (2000).","journal-title":"Revista Medicina"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2017-0270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T20:39:17Z","timestamp":1751229557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2017-0270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.2217\/fmb-2017-0270"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2017-0270","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}